We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

The Covax vaccine initiative — a pooled arrangement to procure vaccines for a number of countries from a range of manufacturers — says that it does not expect delivery timelines to be disrupted despite a decision by the Indian government over the weekend to temporarily ban the export of the Indian-manufactured AstraZeneca Covid-19 vaccine.

The Covax initiative is the only firm commitment that SA has to gain access to a vaccine as the government has not secured orders directly with manufacturers. The Serum Institute of India, which will manufacture the Oxford University-AstraZeneca vaccine, among others, has a major role to play in Covax with an existing agreement to supply 200-million doses...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.